Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients

This study has been completed.
Information provided by (Responsible Party):
AbbVie ( AbbVie (prior sponsor, Abbott) ) Identifier:
First received: March 28, 2008
Last updated: March 14, 2013
Last verified: January 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2006
  Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)